HRT Financial’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$13K Sell
2024
Q3
$32K Buy
2023
Q3
Sell
2023
Q2
$24K Buy
2021
Q2
Sell
2021
Q1
$220K Buy